Latest INVENT Ventures Inc. Stories

Deal Continues INVENT's Series of Investments in Emerging Technology Businesses SANTA MONICA, Calif., March 7, 2013 /PRNewswire/ -- INVENT Ventures, Inc. (OTC QB: IDEA), a seed-stage venture fund and technology incubator, today announced that it has led the seed financing round in Sanguine BioSciences, a biotechnology company empowering patients in biomedical research. Along with INVENT, Heliant Ventures, a VC technology fund, jointly lead the round of investment in Sanguine....

VALENCIA, Calif., Feb. 21, 2013 /PRNewswire/ -- SANGUINE BIOSCIENCES, INC. ("Sanguine"), a biotechnology company empowering patients in biomedical research, has announced the closing of its seed financing round, led by INVENT Ventures and Heliant Ventures. Sanguine engages research subjects through social media and non-profit advocacy, and schedules blood draws, which are then processed into DNA, RNA, cells, plasma, and serum, to be used as biomedical research materials at...

SANTA MONICA, Calif., Oct. 24, 2012 /PRNewswire/ -- INVENT Ventures, Inc. ("INVENT" - http://www.invent.vc) - the only publicly traded venture firm focused exclusively on building startup web and mobile technology companies - today announced that it has completed its transition to INVENT with the change of its stock symbol to IDEA. The company's former name was the Los Angeles Syndicate of Technology, and traded under the stock symbol LAST. INVENT continues to offer retail...

SANTA MONICA, Calif., Sept. 25, 2012 /PRNewswire/ -- INVENT Ventures Inc. ("INVENT"), a seed-stage venture fund and technology incubator, announced today that amendments to its Articles of Incorporation filed with the Nevada Secretary of State went effective that changed its name from Los Angeles Syndicate of Technology Inc. to INVENT Ventures Inc. Additionally, the Company also announced that it has implemented a 3-for-1 forward split of its common stock outstanding. In...